Medical Groups Sue FTC Over Gender-Affirming Care Investigations Amid Trump Policy Dispute 
California Court Rejects xAI Bid to Block AI Data Transparency Law 
Morgan Stanley to Cut 2,500 Jobs as Wall Street Layoffs Continue 
Federal Judge Blocks Virginia Social Media Age Verification Law Over First Amendment Concerns 
SoftBank Seeks Up to $40 Billion Loan to Fund Major Investment in OpenAI 
Inspire Brands IPO Could Raise $2 Billion as Roark Capital Explores Public Listing 
Supreme Court Backs GOP Lawmaker in New York Redistricting Fight Ahead of Midterms 
U.S. Considers New Rules Tying AI Chip Exports to Investment and Security Guarantees 
Federal Judge Orders Refund of Trump’s Emergency Tariffs, Potentially Returning Up to $182 Billion 
Mark Zuckerberg Testifies in Youth Social Media Addiction Trial Over Instagram Policies 
Big Tech Signs White House Pledge to Fund Power for AI Data Centers 
JD.com Misses Q4 Revenue Estimates as China’s Weak Consumer Demand and E-Commerce Competition Intensify 
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes 
DHL Forecasts Higher 2026 Operating Profit Despite Global Shipping Disruptions 
Foxconn Sees Strong Growth Ahead Despite Limited Impact From U.S.–Israel–Iran Tensions 
BYD Launches Next-Generation Blade Battery With 1,000 km Range as EV Competition Intensifies 
 to Recover Losses Announced by Shareholders Foundation - EconoTimes)
The Shareholders Foundation, Inc. announces that a lawsuit was filed in Oregon on behalf of certain purchasers of shares of GNC Holdings Inc (NYSE:GNC) over alleged Securities Laws Violations by GNC Holdings.
Investors who purchased shares of GNC Holdings Inc (NYSE:GNC) have certain options and for certain investors are short and strict deadlines running. Deadline: December 28, 2015. NYSE: GNC investors should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
The plaintiff claims that the defendants issued materially false and misleading statements to investors and/or failed to disclose that GNC Holdings unlawfully sold thousands of units of products in Oregon that contained picamilon, that GNC Holdings unlawfully sold thousands of units of products in Oregon that contained BMPEA, and that as a result of the foregoing, GNC Holdings’ public statements were materially false and misleading at all relevant times.
On October 22, 2015, the State of Oregon sued GNC Holdings Inc, claiming that the company's nutritional and dietary supplements are laced with unapproved drugs, including picamilon and BMPEA. According to the complaint GNC Holdings Inc violated the Oregon Unlawful Trade Practices ACT (“UTPA”) by misrepresenting some of its products as lawful dietary supplements. The complaint alleges that certain products that were misrepresented are unapproved drugs that may not be lawfully sold in the United States as a dietary supplement. In addition, the complaint alleged that GNC Holdings Inc sold products labeled containing botanical acacia rigidula that were added with unlabeled BMPEA and that GNC Holdings Inc allegedly sold thousands of units of products containing picamilon or BMPEA that were falsely labeled as a dietary supplement.
Those who purchased GNC Holdings Inc (NYSE:GNC) shares have certain options and should contact the Shareholders Foundation, Inc. by e-mail at [email protected] or call +1 (858) 779-1554.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
